Talis Biomedical Corporation (TLIS)

USD 1.6

(6.67%)

Total Liabilities Summary of Talis Biomedical Corporation

  • Talis Biomedical Corporation's latest annual total liabilities in 2023 was 29.22 Million USD , down -31.32% from previous year.
  • Talis Biomedical Corporation's latest quarterly total liabilities in 2024 Q2 was 24.07 Million USD , down -6.73% from previous quarter.
  • Talis Biomedical Corporation reported annual total liabilities of 42.55 Million USD in 2022, up 33.59% from previous year.
  • Talis Biomedical Corporation reported annual total liabilities of 31.85 Million USD in 2021, down -89.62% from previous year.
  • Talis Biomedical Corporation reported quarterly total liabilities of 24.07 Million USD for 2024 Q2, down -6.73% from previous quarter.
  • Talis Biomedical Corporation reported quarterly total liabilities of 26.91 Million USD for 2023 Q2, up 17.36% from previous quarter.

Annual Total Liabilities Chart of Talis Biomedical Corporation (2023 - 2018)

Historical Annual Total Liabilities of Talis Biomedical Corporation (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 29.22 Million USD -31.32%
2022 42.55 Million USD 33.59%
2021 31.85 Million USD -89.62%
2020 306.97 Million USD 554.91%
2019 46.87 Million USD -26.04%
2018 63.38 Million USD 0.0%

Peer Total Liabilities Comparison of Talis Biomedical Corporation

Name Total Liabilities Total Liabilities Difference
Acutus Medical, Inc. 54.83 Million USD 46.709%
Biotricity, Inc. 35.91 Million USD 18.64%
Cell MedX Corp. 872.57 Thousand USD -3249.16%
Dynatronics Corporation 11.78 Million USD -148.079%
Nemaura Medical Inc. 26.37 Million USD -10.792%
PetVivo Holdings, Inc. 2.42 Million USD -1102.98%
RetinalGenix Technologies Inc. 1.4 Million USD -1978.797%
Sonendo, Inc. 49.74 Million USD 41.248%
Telesis Bio, Inc. 40.87 Million USD 28.5%
Viveve Medical, Inc. 10.84 Million USD -169.42%